Drs Chan and Hunter discuss asciminib in first-line CML, OPTIC trial data on ponatinib dosing, mutational testing, and stem cell transplant strategies.
Intermountain Healthcare | Strategic Alliance Partners
Latest from Intermountain Healthcare
ASCO has released a research statement outlining 4 recommendations to decentralize clinical trials and improve patient access to these studies.
Advertisement
Advertisement
Trending on OncLive
1
Ensartinib Reduces Recurrence Risk After Resection in ALK-Positive NSCLC
2
FDA Approves Pembrolizumab Plus Enfortumab Vedotin in MIBC
3
Revisit Every OncLive On Air Episode From June 2026
4
FDA Approves Subcutaneous Isatuximab Delivered Via On-Body Delivery System for Multiple Myeloma
5